Home | News & Events | IDEA News | Drug Discovery Institutes to fast-track development of new treatments for dementia

Drug Discovery Institutes to fast-track development of new treatments for dementia

Alzheimer’s Research UK, the world’s largest dedicated dementia research charity, has announced a £30 million Drug Discovery Alliance, launching three flagship Drug Discovery Institutes at the Universities of Cambridge, Oxford and UCL (University College London). The Drug Discovery Institutes will see 90 new research scientists employed in state-of-the-art facilities to fast-track the development of new treatments for Alzheimer’s disease and other dementias.

Read more on the University of Cambridge website here.